Poorly differentiated thyroid carcinoma: An evolving entity

Diagnostic Histopathology

Volumn 17, Issue 3, 2011, Pages 114-123

  Garcia Rostan, Ginesa ^a,b   Sobrinho Simões, Manuel ^b  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Architecture; Cytological features; Diagnosis; Pathobiology; Poorly differentiated thyroid carcinoma; Prognosis

Indexed keywords

B RAF KINASE; BETA CATENIN; PROTEIN P53; RAS PROTEIN; THYROGLOBULIN;

ARTICLE; CANCER DIAGNOSIS; CARCINOGENESIS; CELL DEATH; CLINICAL FEATURE; COMPACT SUBTYPE OF SMALL CELL UNDIFFERENTIATED THYROID CARCINOMA; CYTOPATHOLOGY; DIFFERENTIAL DIAGNOSIS; DISTANT METASTASIS; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; METASTASIS; MITOSIS; MITOSIS INDEX; MOLECULAR DIAGNOSIS; MORPHOLOGY; POORLY DIFFERENTIATED THYROID CARCINOMA; PREVALENCE; PROGNOSIS; PROTEIN EXPRESSION; THYROID CANCER; THYROID CARCINOMA; THYROID FOLLICLE CELL; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; TUMOR DIFFERENTIATION;

EID: 79952123602     PISSN: 17562317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2010.12.001     Document Type: Article

References (39)

1. Sobrinho-Simões M., Albores-Saavedra J., Tallini G., et al. Poorly differentiated carcinoma. Pathology and Genetics of Tumours of Endocrine Organs. World Health Organization Classification of Tumours 2004, 73-76. IARC Press, Lyon. R.A. DeLellis, R.V. Lloyd, P.U. Heitz, C. Eng (Eds.).
2. Hedinger C.H.R., Williams E.D., Sobin L.H. Histologic typing of thyroid tumours 1988, World Health Organization International Histological Classification of Tumours, Springer-Verlag, Berlin. 2nd edn.
3. Rosai J., Carcangiu M.L., DeLellis R.A. Tumors of the thyroid gland. Atlas of tumor pathology 1992, 3rd Series, Armed Forces Institute of Pathology, Washington.
4. Cabanne F., Gerad-Marchant R., Heimann R., Williams E.D. Tumeurs malignes du corps thyroide. Problèmes de diganotic histopathologique. A propos de 692 lèsions recueilles par le groupe coopèrateur des Cancers du Corps Thyroïde de l'O.E.R.T.C. Ann Anat Pathol 1974, 19:129-148.
5. Sakamoto A., Kasai N., Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 1983, 52:1849-1855.
6. Carcangiu M.L., Zampi G., Rosai J. Poorly differentiated (" insular" ) thyroid carcinoma. A reinterpretation of Langhans- " wuchernde Struma" Am J Surg Pathol 1984, 8:655-668.
7. Rosai J. Poorly differentiated thyroid carcinoma: introduction to the issue, its landmarks, and clinical impact. Endocr Pathol 2004, 15:293-296.
8. Sakamoto A. Definition of poorly differentiated carcinoma of the thyroid: the Japanese experience. Endocr Pathol 2004, 15:307-311.
9. Albores-Saavedra J., Carrick K. Where to set the threshold between well differentiated and poorly differentiated follicular carcinomas of the thyroid. Endocr Pathol 2004, 15:297-305.
10. Ashfaq R., Vuitch F., Delgado R., Albores-Saavedra J. Papillary and follicular thyroid carcinomas with insular component. Cancer 1994, 73:416-423.
11. Pilotti S., Collini P., Mariani L., et al. Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland. Am J Surg Pathol 1997, 21:1466-1473.
12. Papotti M., Botto Micca F., Favero A., Palestini N., Bussolati G. Poorly differentiated thyroid carcinomas with primordial cell component. A group of aggressive lesions sharing insular, trabecular and solid patterns. Am J Surg Pathol 1993, 17:291-301.
13. Sobrinho-Simões M., Sambade C., Fonseca E., Soares P. Poorly differentiated carcinomas of the thyroid gland. A review of the clinicopathologic features of a series of 28 cases of a heterogeneous, clinically aggressive group of thyroid tumors. Int J Surg Pathol 2002, 10:123-131.
14. Volante M., Landolfi S., Chiusa L., et al. Poorly differentiated carcinomas of the thyroid with trabecular, insular and solid patterns. A clinicopathologic study of 183 patients. Cancer 2004, 100:950-957.
15. Volante M., Collini P., Nikiforov Y.E., et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 2007, 31:1256-1264.
16. Bongiovanni M., Sadow P.M., Faquin W.C. Poorly differentiated thyroid carcinoma. A cytologic-histologic review. Adv Anat Pathol 2009, 16:283-289.
17. Volante M., Papotti M. Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours. Endocr Pathol 2010, 21:1-6.
18. Pellegriti G., Giuffrida D., Scollo C., et al. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis. Cancer 2002, 95:2076-2085.
19. Nishida T., Katayama S., Tsujimoto M., Nakamura J., Matsuda H. Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol 1999, 23:205-211.
20. Hiltzik D., Carlson D.L., Tuttle R.M., et al. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis. A clinicopathologic study of 58 patients. Cancer 2006, 106:1286-1295.
21. Sobrinho-Simões M., Nesland J.M., Johannessen J.V. Columnar-cell carcinoma. Another variant of poorly differentiated carcinoma of the thyroid. Am J Clin Pathol 1988, 89:264-267.
22. Pilotti S., Collini P., Manzari A., Marubini E., Rilke F. Poorly differentiated forms of papillary thyroid carcinoma: distinctive entities or morphological patterns?. Semin Diagn Pathol 1995, 12:249-255.
23. Rivera M., Ghossein R.A., Schoder H., Gomez D., Larson S.M., Tuttle R.M. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma. Cancer 2008, 113:48-56.
24. Nikiforov Y.E., Erickson L.A., Nikiforova M.N., Caudill C.M., Lloyd R.V. Solid variant of papillary thyroid carcinoma. Incidence, clinical-pathologic characteristics, molecular analysis and biologic behavior. Am J Surg Pathol 2001, 25:1478-1484.
25. Rufini V., Salvatori M., Fadda G., et al. Thyroid carcinomas with a variable insular component: prognostic significance of histopathologic patterns. Cancer 2007, 110:1209-1217.
26. Volante M., Rapa I., Gandhi M., et al. RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact. J Clin Endocrinol Metab 2009, 94:4735-4741.
27. Nikiforov Y.E. Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas. Endocr Pathol 2004, 15:319-327.
28. Garcia-Rostan G., Zhao H., Camp R.L., et al. Ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer. J Clin Oncol 2003, 21:3226-3235.
29. Santoro M., Papotti M., Chiappetta G., et al. RET activation and clinicopathologic features in poorly differentiated thyroid tumors. J Clin Endocrinol Metab 2002, 87:370-379.
30. Soares P., Trovisco V., Rocha A.S., et al. BRAF mutations typical of papillary carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas. Virchows Arch 2004, 444:572-576.
31. Nikiforova M.N., Kimura E.T., Gandhi M., et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 2003, 88:5399-5404.
32. Costa A.M., Herrero A., Fresno M.F., et al. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma. Clin Endocrinol (Oxf) 2008, 68:618-634.
33. Ricarte-Filho J.C., Ryder M., Chitale D.A., et al. Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA and AKT1. Cancer Res 2009, 69:4885-4893.
34. Pita J.M., Banito A., Cavaco B.M., Leite V. Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomas. Br J Cancer 2009, 101:1782-1791.
35. Donghi R., Longoni A., Pilotti S., Michieli P., Della Porta G., Pierotti M.A. Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J Clin Invest 1993, 91:1753-1760.
36. Rocha A.S., Soares P., Fonseca E., Cameselle-Teijeiro J., Oliveira M.C., Sobrinho-Simões M. E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas. Histopathology 2003, 42:580-587.
37. Garcia-Rostan G., Camp R.L., Herrero A., Carcangiu M.L., Rimm D.L., Tallini G. Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. Am J Pathol 2001, 158:987-996.
38. Tallini G., Garcia-Rostan G., Herrero A., et al. Downregulation of p27kip1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Am J Surg Pathol 1999, 23:678-685.
39. Miller K.A., Yeaguer N., Baker K., Liao X.H., Refetoff S., Di Cristofano A. Oncogenic Kras requires simultaneous PI3K signalling to induce ERK activation and transform thyroid epithelial cells in vivo. Cancer Res 2009, 69:3689-3694.